METUPUK welcomes the Scottish Medicines Consortium (SMC) decision to accept pembrolizumab (Keytruda, Merck Sharp and Dohme) plus chemotherapy (paclitaxel or nab-paclitaxel) for use on the NHS in Scotland. Pembrolizumab is
Targeted treatment Piqray with Fulvestrant is approved
METUPUK welcomes the approval of Piqray (alpelisib) plus fulvestrant for the treatment of hormone receptor-positive, HER2-negative, PIK3CA- mutated advanced breast cancer.
Piqray is an exciting new cancer medicine because it is the first targeted treatment option for advanced breast cancer that has a PIK3CA mutation.
Trodelvy Now! Latest Update
METUPUK are delighted that NICE has accepted Trodelvy (sacituzumab govitecan) for routine use on the NHS in England for the treatment of patients with unresectable locally advanced or metastatic triple-negative breast cancer who have received two or more prior lines of systemic therapies. This follows on from the decision to approve Trodelvy in NHS Scotland in March 2022. Wales and Northern Ireland normally follow decisions by NHS England and we hope that Trodelvy will be made available to every patient who is eligible without delay.
Honouring Emma Hillier
Today we want to honour our friend and MetUpUK member Emma Hillier.
Don’t Leave Metastatic Breast Cancer Patients in Wales Behind
A new campaign in Wales, by MetUpUK member Tassia Haines, aims to draw attention to the fact that Metastatic Breast Cancer (MBC) patients feel that they are being failed by the Welsh Government.
Join us as Laura, Mary Helen & Emily discuss primary & secondary breast cancer.
Have you ever wondered what the relationship is like between primary and secondary breast cancer patients when they are talking about cancer?
We’ve put 4 of our MetUpUK members on a zoom call to chat it out – Mary and Laura have secondary cancer and Helen and Emily have had primary breast cancer.
Sex and Intimacy after a Breast Cancer Diagnosis
A diagnosis of cancer is a major life event. None of us is immune to the
potential of developing the disease. It doesn’t discriminate by age, gender,
sexual orientation or ethnicity. It can also develop in any part of the body. In
the case of breast cancer, one in seven women will be diagnosed with it
during their lifetime. Approximately 30% of those women will go on to develop secondary breast cancer.
Laura and Nina talk about their MBC diagnosis
Laura has been living with metastatic breast cancer for 14.5 years, and Nina was diagnosed less than a year ago.
They have been friends since they were teenagers.
Join them as they chat about finding out their cancer was incurable.
Palliative Care – Why it’s important to have an Advanced Care Plan
Hi, I’m Kat, and I’m a nurse at Dr Kershaw’s Hospice in Oldham. You’ve heard from me before and today I wanted to share with you my experiences of supporting Becky, an incredible woman living with metastatic breast cancer, and my thoughts on what I hope early hospice care was able to contribute to her life.
Emma Gilchrist tells us why she is fundraising for METUPUK
“My little sister Helen is 39 years old. She is a married mum of 3 girls, all under the age of 9, and is a nurse with 22 years of service in the RAF. She is a much-loved wife, an adored mummy, a treasured daughter, a dearly loved sister, niece, and aunt, and a favoured friend and colleague to many.